Doulton Tim, Adam Mariyam, Durman Katie, Fan Stanley L S, Forbes Anna, Jenkinson Ed, Mallindine Charlotte, McCafferty Kieran, Sinha Manish D, Stewart Douglas J, Swift Pauline, Dasgupta Indranil
East Kent Hospitals University NHS Foundation Trust, Ashford, UK.
Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
BMC Nephrol. 2025 Sep 26;26(1):532. doi: 10.1186/s12882-025-04451-2.
People with end stage kidney disease receiving dialysis have a very risk of cardiovascular disease and mortality. Hypertension is a modifiable risk factor for cardiovascular disease and mortality, affecting around 90% of dialysis patients. Conversely, intradialytic hypotension in haemodialysis patients is associated with debilitating symptoms as well as the risk of cardiovascular disease and mortality. Blood pressure management in dialysis patients involves accurate measurement of blood pressure, setting a target blood pressure, adequate fluid volume management, lifestyle changes, modification of dialysis and dialysate, and the use of medication with proven efficacy in these patients. However, globally there is no published contemporary clinical practice guideline to assist health care professionals to manage blood pressure in dialysis patients. This is mainly because of a dearth of good quality evidence to inform guideline recommendations. Here, we present a comprehensive guideline to manage blood pressure in dialysis patients based on a thorough systematic review of literature. The guideline development committee comprised a multidisciplinary group of nephrology healthcare professionals and a patient. The evidence underpinning the guidance is often of moderate to low quality, influencing the strength of the recommendations. Therefore, the committee have come up with a list of research recommendations with a view to informing future guidelines. It is envisaged that this guideline will improve the care and outcomes of dialysis patients in the UK and elsewhere.
The online version contains supplementary material available at 10.1186/s12882-025-04451-2.
接受透析的终末期肾病患者患心血管疾病和死亡的风险极高。高血压是心血管疾病和死亡的一个可改变的风险因素,影响着约90%的透析患者。相反,血液透析患者的透析中低血压与使人衰弱的症状以及心血管疾病和死亡风险相关。透析患者的血压管理包括准确测量血压、设定目标血压、进行适当的液体量管理、改变生活方式、调整透析和透析液,以及使用在这些患者中已证实有效的药物。然而,全球范围内尚无已发表的当代临床实践指南来协助医疗保健专业人员管理透析患者的血压。这主要是因为缺乏高质量的证据来为指南建议提供依据。在此,我们基于对文献的全面系统回顾,提出一份管理透析患者血压的综合指南。指南制定委员会由一组多学科的肾病医疗保健专业人员和一名患者组成。支撑该指南的证据质量通常为中等至低等,影响了建议的力度。因此,委员会提出了一系列研究建议,以期为未来的指南提供参考。预计该指南将改善英国及其他地区透析患者的护理和预后。
在线版本包含可在10.1186/s12882-025-04451-2获取的补充材料。